USPTO serial 79307670
MGIGLAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 7, 2022
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- POST REGISTRATION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MGIGLAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Genoria AI Technology Co., Ltd.
CN
Shenzhen, Guangdong, CN
Shenzhen, Guangdong, CN
Guangdong, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles Ho
Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Test paper, chemical; Radioactive elements for scientific purposes; Cultures of microorganisms, other than for medical and veterinary use; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Acids, namely, nucleic acid for laboratory use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use | ACTIVE | — |
| 005 | Bacterial preparations for medical and veterinary use; Chemico-pharmaceutical preparations for medical purposes, namely, for the treatment of cancer and genetic diseases; Cultures of microorganisms for medical or veterinary use; Enzyme preparations for medical purposes; Biological tissue cultures for medical purposes; Biochemical pharmaceuticals for medical purposes, namely, for the treatment of cancer and genetic diseases; Blood products for medical purposes, namely, blood plasma and cord blood; Medical diagnostic reagents; Chemical reagents for medical or veterinary purposes; Preparations for detecting genetic predispositions for medical purposes | ACTIVE | — |
| 009 | Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Apparatus and measuring instruments for physical and chemical test and composition analysis, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics and contaminants all for scientific purposes; DNA chips; Gene amplification instrument for scientific research purposes; Laboratory apparatus and instruments, namely, gene analyzers for genome information; Testing apparatus not for medical purposes namely, research laboratory analyzers for testing blood and other bodily fluids and electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; Laboratory equipment, namely, protein sequence analysis apparatus; Diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Computer operating programs, recorded; Downloadable computer programs for biological data mining; Downloadable computer programs for developing bioinformatics database for others; Downloadable computer programs for analyzing genome information | ACTIVE | — |
| 010 | Medical apparatus for detecting gene, namely, flow cytometers and flow-based analyzers providing cell and particle analysis and detection for medical use; Apparatus for DNA and RNA testing for medical purposes; Probes for medical purposes; Medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments, namely, apparatus for detecting tumor cancer and genetic diseases; Medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; Apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; Testing apparatus for medical purposes, namely, blood testing apparatus, immunochemical testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic apparatus for testing blood sugar levels, cancer cells and DNA; X-ray apparatus for medical purposes; Radiological apparatus for medical purposes; Ultrasonic diagnostic apparatus for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genoria AI Technology Co., Ltd.
- Other trademarks owned by MGI TECH CO., LTD.
- Other trademarks owned by MGI TECH CO., LTD.
- Other trademarks owned by MGI TECH CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named MGIGLAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 11, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jun 6, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 28, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 25, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 31, 2022 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Oct 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 20, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 19, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 7, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 7, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 30, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 12, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 12, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 12, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 30, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 13, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 13, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 13, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 19, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 1, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 28, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 2, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |